DEFERRED RD OBLIGATIONS PARTICIPATION AGREEMENTS (Details Narrative) |
3 Months Ended | |
|---|---|---|
|
Mar. 31, 2025
USD ($)
integer
shares
|
Mar. 31, 2024
shares
|
|
| Number of license co-development participation agreements | integer | 21 | |
| Revenue Share | 44.78% | |
| Proceeds from sales as future revenues | $ 2,985,000 | |
| Warrants issued and sold | shares | 17,712 | |
| Warrants issued and value | $ 953,897 | |
| Deferred revenue | $ 2,031,103 | |
| Annual rate of dividends | 0.00% | |
| Shares issued for liability cancellation | $ 5,306,500 | |
| Stock Issued During Period, Shares | shares | 131,380 | |
| Stock Issued During Period, Value | $ 3,284,500 | |
| Stock Issued During Period, Shares, Other | shares | 47,320 | 407,299 |
| Non-cash research and development expense | $ 2,508,261 | |
| Exchange agreements - related party | $ 862,473 | |
| Bottom [Member] | ||
| Volatilities rate | 129.13% | |
| Discount rate | 0.26% | |
| Top [Member] | ||
| Volatilities rate | 154.26% | |
| Discount rate | 0.87% | |
| X | ||||||||||
- Definition The number of warrants issued in exchange for the original debt being converted in a noncash (or part noncash) transaction. "Part noncash" refers to that portion of the transaction not resulting in cash receipts or cash payments in the period. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Amount of revenue recognized that was previously reported as deferred or unearned revenue. No definition available.
|
| X | ||||||||||
- Definition The cash inflow from issuance of rights to purchase common shares at predetermined price (usually issued together with corporate debt). Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition The cash inflow resulting from the sale of loans classified as held-for-sale, including proceeds from loans sold through mortgage securitization. Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
| X | ||||||||||
- Definition Restrictions on equity-based instruments during the vesting period, such as the inability to transfer unvested awards, are not taken into account in estimating the fair value of the award. However, restrictions that remain in effect after an award is vested, such as the inability to transfer or hedge vested options or a prohibition on the sale of outstanding vested shares (or other type of equity) for a period of time, affect the estimate of an award's fair value. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition The estimated measure of the percentage by which a share price is expected to fluctuate during a period. Volatility also may be defined as a probability-weighted measure of the dispersion of returns about the mean. The volatility of a share price is the standard deviation of the continuously compounded rates of return on the share over a specified period. That is the same as the standard deviation of the differences in the natural logarithms of the stock prices plus dividends, if any, over the period. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Number of new stock issued during the period. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Number of shares of stock issued attributable to transactions classified as other. No definition available.
|
| X | ||||||||||
- Definition Equity impact of the value of new stock issued during the period. Includes shares issued in an initial public offering or a secondary public offering. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- References No definition available.
|
| X | ||||||||||
- References No definition available.
|
| X | ||||||||||
- References No definition available.
|
| X | ||||||||||
- References No definition available.
|
| X | ||||||||||
- References No definition available.
|
| X | ||||||||||
- References No definition available.
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|